A startup incubated by UNIST has successfully gone public on the KOSDAQ, marking a milestone in its research-to-commercialization growth strategy.
According to UNIST, RecensMedical, listed on the KOSDAQ market, was founded in 2016 as a faculty startup.
The company develops precision cooling medical devices used in dermatology, ophthalmology and veterinary care, based on rapid precision cooling technology from the laboratory of Professor Kim Geon-ho in the mechanical engineering department at UNIST.
Its core technology enables real-time monitoring of biological tissue temperature and precise control of cooling intensity and duration tailored to the treatment area. The approach reduces pain and shortens procedure time compared to conventional methods that rely on chemical anesthesia.
The company received startup support from UNIST throughout its development, including technology validation, product commercialization and global expansion. UNIST’s GMP-certified production facilities played a key role in obtaining regulatory approval from Ministry of Food and Drug Safety.
Through a global startup mentoring program operated by UNIST at UC San Diego, the company has refined its U.S. clinical and business strategies since 2018.
RecensMedical has continued its growth through investment after establishing a foundation for commercialization and exports. It was selected as Ulsan’s first TIPS startup team in 2017 and later received funding in 2022 from a fund managed by UNIST’s subsidiary, UNIST Holdings.
Co-CEO Kim said the company will accelerate its global expansion by obtaining overseas regulatory approvals and strengthening its sales network.
UNIST President Park Jong-rae said the institute is strengthening its startup platform by supporting investment at each growth stage and expanding global collaboration, adding that it will continue to help research outcomes translate into startups and industrial applications to enhance national competitiveness.
